Seer (SEER) Liabilities and Shareholders Equity (2020 - 2026)

Seer (SEER) recorded quarterly Liabilities and Shareholders Equity of $272.1 million in Q1 2026, down 8.09% quarter-over-quarter from $296.1 million in Q4 2025, and down 21.63% on a YoY basis from $347.3 million in Q1 2025.

Seer (SEER) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Seer's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $272.1 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 21.63% year-over-year to $272.1 million; the TTM figure through Mar 2026 stood at $1.2 billion (down 20.25% YoY), while the FY2025 annual figure was $296.1 million, down 19.23% from the prior year.
  • Liabilities and Shareholders Equity was $272.1 million for Q1 2026 at Seer, down from $296.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $527.1 million in Q1 2022 to a low of $272.1 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $410.1 million across 5 years, with a median of $422.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity retreated 3.4% in 2022, then slipped 21.63% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $487.9 million in 2022, then slipped by 10.59% to $436.3 million in 2023, then decreased by 15.97% to $366.6 million in 2024, then decreased by 19.23% to $296.1 million in 2025, then declined by 8.09% to $272.1 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $272.1 million (Q1 2026), $296.1 million (Q4 2025), and $308.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 37.37 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 811.27 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 14.93 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 1.73 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 33.89 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 23.64 Mn
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 26.48 Bn
9 Abivax 94.37 Bn 94.37 Bn - 640.56 Mn
10 Seer 99.67 Mn 99.67 Mn 982,000.00 272.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 272.13 Mn
Dec 31, 2025 296.08 Mn
Sep 30, 2025 308.61 Mn
Jun 30, 2025 322.49 Mn
Mar 31, 2025 347.26 Mn
Dec 31, 2024 366.60 Mn
Sep 30, 2024 383.42 Mn
Jun 30, 2024 406.61 Mn
Mar 31, 2024 421.96 Mn
Dec 31, 2023 436.27 Mn
Sep 30, 2023 444.85 Mn
Jun 30, 2023 461.20 Mn
Mar 31, 2023 472.79 Mn
Dec 31, 2022 487.93 Mn
Sep 30, 2022 500.21 Mn
Jun 30, 2022 516.30 Mn
Mar 31, 2022 527.09 Mn
Dec 31, 2021 539.14 Mn
Sep 30, 2021 527.84 Mn
Jun 30, 2021 537.05 Mn